Your browser doesn't support javascript.
loading
Comparison of the pathological response to 2 or 4 cycles of neoadjuvant CAPOX in II/III rectal cancer patients with low/intermediate risks: study protocol for a prospective, non-inferior, randomized control trial (COPEC trial).
Shen, Yu; Shi, Wanyue; Huang, Cui; Gong, Xiaoling; Wei, Mingtian; Meng, Wenjian; Deng, Xiangbing; Wang, Ziqiang.
Afiliação
  • Shen Y; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China.
  • Shi W; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China.
  • Huang C; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China.
  • Gong X; Department of Radiology, West China Hospital, Sichuan University, Sichuan Province, Guo Xue Xiang 37#, Chengdu, China.
  • Wei M; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China.
  • Meng W; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China. mengwenjian@126.com.
  • Deng X; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China. 247940362@qq.com.
  • Wang Z; Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan UniversitySichuan Province, Chengdu, China. wangziqiang@scu.edu.cn.
Trials ; 24(1): 397, 2023 Jun 13.
Article em En | MEDLINE | ID: mdl-37312165

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article